Blood test could predict chemo side effects in brain cancer patients
NCT ID NCT02617745
First seen Jan 04, 2026 · Last updated Jun 11, 2026 · Updated 25 times
Summary
This study looked at 244 people with a newly diagnosed brain cancer called glioblastoma. Researchers wanted to see if changes in platelet levels during early treatment could predict who might develop dangerously low platelets later. The goal was to create a simple monitoring plan to catch this side effect early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Henri Becquerel
Rouen, 76038, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.